Press Releases

Sep 18, 2019
Covalon Announces Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Sep. 18, 2019-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that, further to its press release dated September 6, 2019 , it has completed a non-brokered private
Sep 06, 2019
Covalon Announces Re-Pricing of Private Placement
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Sep. 6, 2019-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has re-priced its non-brokered private placement originally announced on August 1, 2019 (the
Aug 27, 2019
Covalon Announces Third Quarter Fiscal 2019 Results
Conference call scheduled for Wednesday August 28 th , 2019 at 9:00am EST   MISSISSAUGA, Ontario --(BUSINESS WIRE)--Aug. 27, 2019-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal
Aug 01, 2019
Covalon Announces Private Placement of Up To $6.3 Million
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Aug. 1, 2019-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that the Company intends to raise up to an aggregate of $6.3 million in one or more closings (the
Jul 25, 2019
Covalon CEO Provides Corporate Update
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jul. 25, 2019-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, wishes to provide the following corporate update: The team at Covalon continues to make progress in strengthening our
May 28, 2019
Covalon Announces Second Quarter Fiscal 2019 Results
Revenue for the three months ended March 31 st , 2019, was $13.3 million , up 132% Gross margin for the quarter ended March 31 st , 2019, was 69% Net loss for the quarter was $0.2 million or $0.01 per share, compared to a loss of $0.4 million or $0.02 per share last year Conference call scheduled
May 27, 2019
Covalon Announces Conference Call to Discuss Second Quarter Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)--May 27, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2019 Second Quarter financial results on Tuesday May 28 th , 2019, after markets close.
Apr 08, 2019
Covalon’s Award-Winning MediClear PreOp Product Recognized as Innovative Solution to Help Hospitals Reduce Surgical Site Infections
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 8, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF) is pleased to announce that its MediClear™ PreOp product has been recognized by both the medical device industry and by key clinicians as an important innovation in
Mar 18, 2019
Mr. Ron Smith Joins Covalon’s Board of Directors and is Appointed Chair of the Audit Committee
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar. 18, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announced that Mr. Ron Smith has joined Covalon’s Board of Directors and has been appointed Chair of Covalon’s
Mar 08, 2019
Covalon Announces Voting Results from 2019 Annual and Special Meeting of Shareholders
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar. 8, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, today announces the results of the matters voted upon at the Company’s 2019 Annual and Special Meeting of Shareholders on
Feb 26, 2019
Covalon Announces First Quarter Fiscal 2019 Results and Updates Plans for Fiscal 2019
Q1 Fiscal 2019 revenue in line with expectations at $7.2 million up 13% compared to last year Fiscal 2019 contracted Middle East revenue expected to be approximately $30 million , more than double the contracted revenue of fiscal 2018 Fiscal 2019 revenue in United States on track to exceed $25
Feb 21, 2019
Covalon Announces Conference Call to Discuss First Quarter Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Feb. 21, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2019 First Quarter financial results on Tuesday February 26 th , 2019, after markets
Jan 30, 2019
Mr. John Suk Joins Covalon’s Board of Directors
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jan. 30, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. John Suk has joined Covalon’s Board of Directors. Mr.
Jan 28, 2019
Dr. Myrna Francis Joins Covalon’s Board of Directors
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jan. 28, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Dr. Myrna Francis has joined Covalon’s Board of Directors. Dr.
Jan 24, 2019
Covalon Announces Change of Auditors and Amends and Restates Its Rolling Stock Option Plan
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jan. 24, 2019-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today that it has appointed PricewaterhouseCoopers LLP (“Successor Auditor”) as its auditor.